CASE STUDIES

To help optimize learning, each section of the case study has a review test with feedback for both correct and incorrect answers to help you better understand.

CASE STUDY 1

Matt Hukill, PhD, MS, MBA, MLS(ASCP)CM SBBCM
Product Manager, Hemo bioscience, Inc.

SECTION 1

Background:

GP, a 68-year-old retired high school chemistry teacher, recently presented to his primary care physician with complaints of persistent fatigue, new onset back pain, and noticeable pallor over the past few months. GP, who has always prided himself on his active lifestyle and daily morning walks with his wife of 42 years, SP, first noticed something was wrong when he began struggling to keep up with his usual routines.

Initially, GP attributed his symptoms to "getting older.” However, his back pain became so severe recently that he missed tending to his garden several days in the same week. Gardening is a hobby he's pursued with relentless stubbornness for the past three years, no matter how he felt or what was going on around him. Missing those days worried his wife enough that she insisted he see their family physician right away.

GP's medical history includes well-controlled hypertension and high cholesterol, managed with lisinopril and atorvastatin. He has no known allergies and no prior history of blood transfusions. His family history is mostly insignificant, except for his father having died from "blood cancer" in the 1980s, though specific details were never shared with GP as it was a thing you just didn’t discuss at the time.

GP’s initial blood work revealed some concerning findings, including anemia (hemoglobin 8.2 g/dL), elevated protein levels, and abnormal kidney function. GP was referred to an oncologist for additional testing, including a bone marrow biopsy and imaging studies, after which he received the unexpected diagnosis of Multiple Myeloma. The news came as a shock to both GP and his wife, who had been planning their first European river cruise for their upcoming 43rd wedding anniversary.

GP's oncologist is now coordinating further evaluations and planning for treatment, which is expected to include an Anti-CD38 monoclonal antibody as part of a combination therapy regimen. Before initiating therapy, baseline laboratory studies are ordered, including a complete blood count (CBC) and a type and screen to establish his blood type and assess for any red cell antibodies, as transfusions may be required during the course of his treatment.

Initial ABO/Rh Type

ANTI-A ANTI-B ANTI-D Rh CONTROL A1 CELLS B CELLS

1+

1+

4+

1+

3+

3+

Initial Antibody Screen

IS IAT-PEG CC

SCI

1+

0

2+

SCII

1+

0

2+

SCIII

1+

0

2+

AUTO

1+

0

2+

Investigation:

The initial ABO/Rh typing results presented a puzzling discrepancy that needed resolution before GP could receive any transfusions during his upcoming treatment. The blood bank technologist noted that all of the testing with the patient’s red cells in the ABO/Rh typing was reactive, but most of it was weaker than what is usually seen.  Meanwhile, the reverse typing displayed more expected reactivity strengths seen in positive reverse type reactions with both A1 cells and B cells.

The antibody screen also showed weak reactions at the immediate spin (IS) phase and no reactivity at the Anti-Human Globulin (AHG) phase for all screen cells and the auto control, while the Coombs control cells reacted appropriately at 2+.

SECTION 2

Investigation:

Given GP's diagnosis, the blood bank technologist decides that the more likely result to be abnormal is the weak reactions in the forward type due to excessive abnormal proteins in the specimen. They decide to repeat the tests after thoroughly washing GP's red cells to remove any interfering proteins. They also suspect rouleaux may be causing the reactivity in the antibody screen at IS and perform the saline replacement technique for tests that use GP's plasma.

ABO/Rh Forward Type with Washed RBCs

ANTI-A ANTI-B ANTI-D Rh CONTROL

0

0

4+

0

Reverse Type with Saline Replacement

A1 CELLS B CELLS

3+

3+

Antibody Screen with Saline Replacement/Washed Cells for Auto Control (IS Phase)

IS

SCI

0

SCII

0

SCIII

0

AUTO

0

CONCLUSION & DISCUSSION

Conclusion:

Washing GP’s red cells effectively removed the excess plasma proteins that were causing nonspecific weak agglutination in the initial forward typing, while utilizing the saline replacement technique eliminated the rouleaux formation that was creating pseudo agglutination in the antibody screen.

These results confirmed GP's blood type as group O, RhD positive, resolving the initial discrepancy and establishing his baseline for transfusion support. With his correct blood type now determined, and his antibody screen negative, GP can proceed with his Multiple Myeloma treatment plan knowing that compatible blood products will be readily available if needed during his therapy.

Getting this sorted out is one less thing for GP and SP to worry about as they navigate his new diagnosis and his treatment plan. SP was relieved to have clear answers after all the confusing test results, while GP found some comfort in understanding the logical steps the laboratory took to solve the problem—much like the systematic approach he used to take with his chemistry students. Their anniversary cruise will have to wait, but at least now they know that if GP needs blood products during treatment, everything will be ready. Maybe by next year, he'll be back to his stubborn daily garden routine, and they can finally take that trip.

Discussion:

In patients with Multiple Myeloma, like GP, the disease involves the abnormal proliferation of plasma cells that produce large amounts of a single type of antibody, known as a monoclonal protein or M-protein (paraprotein). This significant increase in plasma proteins can lead to a few common problems in blood bank testing.

The most common issue is rouleaux, where the excess proteins in the patient's plasma alter the surface charge environment around red cells, causing them to stack on top of each other in the test tube and resemble stacks of coins if viewed microscopically. This is not true agglutination, where antibodies bridge red cells together, but it can look like weak agglutination in test tubes or on slides, especially at IS or RT phases of testing. This is why GP's initial ABO/Rh typing and antibody screen showed weak positive reactions that disappeared after troubleshooting.

The saline replacement technique is used to resolve rouleaux when performing tests that use the patient’s plasma. It is performed by removing the patient's protein-rich plasma after centrifugation, without disturbing the cell button, and replacing it with equal amounts of saline. If a true antigen-antibody complex was formed, the red cells will remain agglutinated together. However, if an antigen-antibody complex was not formed and the reactivity was due to rouleaux, the red cells should cleanly disperse in the saline and give a more clearly negative result.

Sometimes those excessive proteins coat the patient's red cells directly and cause false positive reactions in tests utilizing the patient’s red cells due to rouleaux. The saline replacement technique cannot resolve these false positive reactions the same way it can in tests involving the patient’s plasma and reagent red cells. This is because the interfering proteins are attached to the patient’s red cells and not floating in the surrounding plasma like they are in reverse type testing or antibody screen testing.  Thoroughly washing the patient's red cells with saline before performing these tests removes the interfering plasma proteins and allows the typing reagents to interact directly and accurately with the antigens present on the red cell surface, if present, and give good strong reactions, or give cleaner negative results.

So, in GP's case, his Multiple Myeloma led to an excess of plasma proteins, which caused both the rouleaux seen in the initial antibody screen and in his initial forward ABO and Rh typing. The investigative steps of washing the cells and using saline replacement allowed us to 'see through' these protein-related interferences and determine his true blood type and antibody status.

Questions, answers, and helpful feedback submitted after completing the Case Study Review will be posted here.